ArticleThe journal of Tehran Heart Center2024
Efficacy of the Optimal Dosage of Lisinopril in Inhibiting Myofibroblast Differentiation for Attenuating Rheumatic Heart Disease Progression: An in Vitro Study.
Achmad Lefi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.